Active substance
Results for the substance golimumab
5 results
About this active substance
Golimumab is a monoclonal antibody used for the treatment of chronic inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, and ulcerative colitis. It works by inhibiting tumor necrosis factor-alpha (TNF-alpha), a protein involved in inflammation.
The medication is administered via subcutaneous injection, usually once a month, as directed by a physician. Golimumab has shown efficacy in reducing symptoms and slowing disease progression.
Common side effects include upper respiratory tract infections, injection site reactions, and headaches. It is important for patients to be monitored for signs of infections or other complications.
Golimumab is a modern and effective option for patients with chronic inflammatory diseases, helping to improve their quality of life.
The medication is administered via subcutaneous injection, usually once a month, as directed by a physician. Golimumab has shown efficacy in reducing symptoms and slowing disease progression.
Common side effects include upper respiratory tract infections, injection site reactions, and headaches. It is important for patients to be monitored for signs of infections or other complications.
Golimumab is a modern and effective option for patients with chronic inflammatory diseases, helping to improve their quality of life.
-
-
GOTENFIA 50mg solution for injection in pre-filled syringe STADA
-
SIMPONI 50mg/0.5ml solution for injection in pre-filled pen JANSSEN ORIGINAL MEDICINE
-
SIMPONI 100mg/ml solution for injection JANSSEN ORIGINAL MEDICINE
-
SIMPONI 50mg/0.5ml solution for injection in pre-filled syringe CENTOCOR ORIGINAL MEDICINE